EXPERIMENT 7:
CATALYTIC ASYMMETRIC DIHYDROXYLATION OF OLEFINS
To
prepare
an
enantiomerically
enriched
1,2-diol
using
Sharpless'
catalytic
asymmetric
dihydroxylation procedure, and to estimate the enantiomeric purity of the material you obtain.
Asymmetric catalysis; recrystallisation; measurement of optical rotations.
The need to prepare compounds such as drug candidates in enantiomerically pure form means that
the organic chemist needs at his/her disposal a wide range of small chiral organic molecules from
which to construct their target molecules. One source of these chiral starting materials (sometimes
called 'chirons') is nature itself. However, such a 'chiral pool' supply is necessarily limited - the
pool may not contain a particular type of starting material, or it may only be available as the
opposite enantiomer to the one needed.
Thus, chemists have begun to devise methods for the synthesis of
both
enantiomers of useful
small molecules from achiral starting materials.
1
This
can
be
achieved
through
temporary
attachment of a chiral auxiliary to the achiral material (the synthesis is then diastereoselective,
rather than enantioselective); use of chiral reagents; or the use of chiral catalysts. The latter
approach,2
though the less well developed of the three, is potentially the most interesting, since a
small amount of chiral catalyst can produce large amounts of enantiomerically enriched product.
One of the pioneers of this field has been Professor K Barry Sharpless of the Scripps Research
Institute. The eponymous epoxidation of allylic alcohols
3
was the first practical and reliable
catalytic asymmetric reaction, and more recently he has turned his attention to the asymmetric
osmium mediated dihydroxylation
4
(see scheme) and aminohydroxylation
5
of olefins, using
modified cinchona alkaloids as chiral ligands for osmium.
Chemistry, Imperial
College
Advanced Practical Organic
Chemistry



H
H
H
N
dihydroquinine
H
N
dihydroquinidine
M
R
S
R
L
α
-face
predicting the
sense of asymmetric
induction in AD reactions
4
+
Ligand
L
O
O
2
PHAL